News + Filings Holdings
|
Artal Group S.A.
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
CAVA GROUP, INC.
| CAVA | Common | 32,007,990 | 32,007,990 | 1,310,727,000 | 1,310,727,000 | 40.62 | |
Hist
| 06/30/2023 |
LEXICON PHARMACEUTICALS, INC.
| LXRX | COM NEW | 117,553,284 | 27,775,050 | 269,197,000 | 51,036,000 | 8.34 | 62.29 |
Hist
| 06/30/2023 |
Morphic Holding, Inc.
| MORF | Common | 2,139,995 | 326,046 | 122,686,000 | 54,409,000 | 3.80 | 5.41 |
Hist
| 06/30/2023 |
Paragon Airheater Technologies, Inc.
| APLS | COM | 1,050,067 | -166,245 | 95,661,000 | 15,433,000 | 2.96 | |
Hist
| 06/30/2023 |
Mirati Therapeutics, Inc.
| MRTX | COM | 2,055,181 | 517,472 | 74,254,000 | 17,082,000 | 2.30 | 3.53 |
Hist
| 06/30/2023 |
BeiGene, Ltd.
| BGNE | ADR | 412,496 | -88,839 | 73,548,000 | -34,505,000 | 2.28 | |
Hist
| 06/30/2023 |
Scholar Rock Holding Corp
| SRRK | Common | 9,059,507 | 31,557 | 68,309,000 | -3,915,000 | 2.12 | 16.69 |
Hist
| 06/30/2023 |
Revolution Medicines, Inc.
| RVMD | Common | 2,401,617 | 330,629 | 64,243,000 | 19,385,000 | 1.99 | 2.26 |
Hist
| 06/30/2023 |
AMICUS THERAPEUTICS, INC.
| FOLD | COM | 4,562,567 | 1,036,160 | 57,306,000 | 18,198,000 | 1.78 | 1.61 |
Hist
| 06/30/2023 |
Cerevel Therapeutics Holdings, Inc.
| CERE | Common | 1,638,858 | -275,608 | 52,099,000 | 5,405,000 | 1.61 | 1.05 |
Hist
| 06/30/2023 |
SpringWorks Therapeutics, Inc.
| SWTX | Common | 1,816,620 | -729 | 47,632,000 | 853,000 | 1.48 | 2.91 |
Hist
| 06/30/2023 |
CYTOKINETICS INC
| CYTK | COM NEW | 1,416,031 | 49,008 | 46,191,000 | -1,915,000 | 1.43 | 1.49 |
Hist
| 06/30/2023 |
Kymera Therapeutics, Inc.
| KYMR | Common | 1,805,346 | 0 | 41,505,000 | -11,987,000 | 1.29 | 3.27 |
Hist
| 06/30/2023 |
Krystal Biotech, Inc.
| KRYS | Common | 349,669 | -62,413 | 41,051,000 | 8,060,000 | 1.27 | 1.36 |
Hist
| 06/30/2023 |
ACELYRIN, Inc.
| SLRN | Common | 1,821,214 | 1,821,214 | 38,063,000 | 38,063,000 | 1.18 | |
Hist
| 06/30/2023 |
Schrodinger, Inc.
| SDGR | Common | 700,000 | 0 | 34,944,000 | 16,513,000 | 1.08 | 0.98 |
Hist
| 06/30/2023 |
AGENUS INC
| AGEN | Common Stock | 15,631,235 | 0 | 25,010,000 | 1,251,000 | 0.78 | 4.48 |
Hist
| 06/30/2023 |
Denali Therapeutics Inc.
| DNLI | Common | 802,899 | 0 | 23,694,000 | 5,195,000 | 0.73 | 0.59 |
Hist
| 06/30/2023 |
Sage Therapeutics, Inc.
| SAGE | COM | 500,000 | -250,000 | 23,510,000 | -7,960,000 | 0.73 | |
Hist
| 06/30/2023 |
IGM Biosciences, Inc.
| IGMS | Common | 2,522,244 | 12,272 | 23,280,000 | -11,207,000 | 0.72 | 5.84 |
Hist
| 06/30/2023 |
Allovir, Inc.
| ALVR | Common | 6,597,167 | 1,020,000 | 22,430,000 | 456,000 | 0.70 | |
Hist
| 06/30/2023 |
Kura Oncology, Inc.
| KURA | Common | 2,018,056 | 300,000 | 21,351,000 | 339,000 | 0.66 | 2.95 |
Hist
| 06/30/2023 |
MoonLake Immunotherapeutics
| MLTX | Common | 400,000 | 400,000 | 20,400,000 | 20,400,000 | 0.63 | 0.76 |
Hist
| 06/30/2023 |
Sea Ltd
| SE | SPONSORED ADS | 350,000 | 47,500 | 20,314,000 | -5,867,000 | 0.63 | |
Hist
| 06/30/2023 |
Seer, Inc.
| SEER | Common | 4,750,000 | 0 | 20,283,000 | 1,948,000 | 0.63 | |
Hist
| 06/30/2023 |
Vigil Neuroscience, Inc.
| VIGL | Common | 1,911,191 | -332,161 | 17,965,000 | -3,997,000 | 0.56 | 5.36 |
Hist
| 06/30/2023 |
GERON CORP
| GERN | COM | 5,565,889 | 0 | 17,867,000 | 5,789,000 | 0.55 | 1.09 |
Hist
| 06/30/2023 |
Roivant Sciences Ltd.
| ROIV | COM | 1,625,000 | 1,025,000 | 16,380,000 | 11,952,000 | 0.51 | |
Hist
| 06/30/2023 |
Generation Bio Co.
| GBIO | Common | 2,814,191 | 0 | 15,478,000 | 3,377,000 | 0.48 | 4.29 |
Hist
| 06/30/2023 |
Relay Therapeutics, Inc.
| RLAY | Stock | 1,213,725 | -460,018 | 15,244,000 | -12,323,000 | 0.47 | 1.00 |
Hist
| 06/30/2023 |
GLYCOMIMETICS INC
| GLYC | COM | 8,589,064 | 0 | 14,945,000 | 4,123,000 | 0.46 | |
Hist
| 06/30/2023 |
ImmunoGen, Inc.
| IMGN | COM | 765,497 | 765,497 | 14,445,000 | 14,445,000 | 0.45 | 0.34 |
Hist
| 06/30/2023 |
Omega Therapeutics, Inc.
| OMGA | Common | 2,533,045 | 0 | 14,185,000 | -1,089,000 | 0.44 | 4.60 |
Hist
| 06/30/2023 |
Protagonist Therapeutics, Inc
| PTGX | Common | 500,000 | 500,000 | 13,810,000 | 13,810,000 | 0.43 | 0.98 |
Hist
| 06/30/2023 |
Ventyx Biosciences, Inc.
| VTYX | Common | 408,519 | -127,293 | 13,399,000 | -4,551,000 | 0.42 | 0.70 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|